Breakthrough in Infertility Treatment: rhFSH-CTP Shows Promise in Clinical Trials
A novel long-acting recombinant human follicle-stimulating hormone, rhFSH-CTP, has demonstrated significant potential in improving infertility treatment outcomes. Clinical trials reveal that rhFSH-CTP can reduce the number of required injections, enhance patient compliance, and maintain therapeutic efficacy, marking a significant advancement in assisted reproductive technologies.
© Copyright 2025. All Rights Reserved by MedPath